About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in Houston | 425 Studies

Clinical Trials Pancreatic CancerHouston

Pancreatic Cancer Clinical Trials in Houston

Find 425 clinical trials for pancreatic cancer near Houston, Texas. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 281-300 of 425 trials

Active not recruitingAn Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of RuxolitinibThe purpose of this study is to provide continued supply of ruxolitinib alone, ruxolitinib plus background cancer therapy, or background cancer therapy alone to subjects from an…NCT02955940·Santa Monica, California and 8 others CompletedRadiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic CancerRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells.NCT00003591·Birmingham, Alabama and 233 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

Active not recruitingSafety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCThis is a First-in-Human Phase IA/IB/II open label dose escalation study of intravenous (IV) administration of ONC-392, a humanized anti-CTLA4 IgG1 monoclonal antibody, as single…NCT04140526·Springdale, Arkansas and 36 others

CompletedYttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN StudyThis research registry studies Yttrium Y 90 resin microspheres in collecting data from patients with liver cancer not capable of being removed by surgery (unresectable) for the…NCT02685631·Birmingham, Alabama and 41 others

CompletedA Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic CancerThe purpose of this study is to determine whether an investigational immuno-therapy, cabiralizumab in combination with nivolumab, with or without chemotherapy, is effective for…NCT03336216·Phoenix, Arizona and 40 others

TerminatedA Study of Zilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002)This is a study evaluating the efficacy, safety, and pharmacokinetics of zilovertamab vedotin in participants with metastatic solid tumors including previously treated cancers of…NCT04504916·Hollywood, Florida and 13 others

CompletedA Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid TumorsThe purpose of this study is to determine the recommended dose of siltuximab monotherapy, in participants with solid malignant (cancerous) tumors (a mass in a specific area) and…NCT00841191·Philadelphia, Pennsylvania and 11 others

CompletedNab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic CancerThis phase I trial studies the side effects and best dose of nab-paclitaxel when given together with capecitabine and radiation therapy following first treatment with chemotherapy…NCT02394535·Houston, Texas and 4 others

TerminatedVorinostat Plus Radiation Therapy in Pancreatic CancerPrimary Endpoint: To determine the maximum tolerated dose (MTD) of vorinostat + radiation therapy (RT) in patients with locally advanced pancreatic cancer (LAPC).NCT00831493·Houston, Texas

CompletedARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic CancerThe study will document the safety and efficacy of the combination of ARQ 501 and gemcitabine in patients with treatment-naïve, unresectable, metastatic pancreatic adenocarcinoma.NCT00102700·Mobile, Alabama and 14 others

Active not recruitingNBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic CancerTo find the recommended dose of NBTXR3 that can be given in combination with radiation therapy to patients with pancreatic cancer.NCT04484909·Houston, Texas

Active not recruitingA Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)The purpose of this study is to assess the safety and efficacy of Navlimetostat (BMS-986504), a selective, MTA-cooperative PRMT5 inhibitor, in combination with…NCT07076121·Phoenix, Arizona and 268 others

RecruitingA Study of ERAS-0015 in Patients With Advanced or Metastatic Solid TumorsThe main purpose of the study is to assess whether the study drug, ERAS-0015, is safe and tolerable when administered to patients with advanced or metastatic solid tumors with…NCT06983743·Santa Rosa, California and 8 others

CompletedChemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic CancerRATIONALE: Drugs used in chemotherapy, such as cisplatin and fluorouracil, use different ways to stop tumor cells from dividing so they stop growing or die.NCT00068575·Houston, Texas

Active not recruitingStudy of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal AdenocarcinomaThe purpose of this study is to compare overall survival of quemliclustat, nab-paclitaxel and gemcitabine versus placebo, nab-paclitaxel and gemcitabine in all randomized patients.NCT06608927·Phoenix, Arizona and 110 others

CompletedEvaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative TherapyThe purpose of this study is to determine whether the early identification and more precise intervention of operating room (OR) patient fluid administration optimization using…NCT00526331·Houston, Texas

TerminatedA Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid TumorsThis is an open-label, multicenter, First-In-Human (FIH), Phase 1a/1b study of PY159 in subjects with locally advanced (unresectable) and/or metastatic solid tumors that are…NCT04682431·Los Angeles, California and 16 others

TerminatedA Study of Live Biotherapeutic Product MRx0518 With Hypofractionated Radiation Therapy in Resectable Pancreatic CancerThis is a single center, open-label, phase I study to evaluate the safety and preliminary efficacy of MRx0518 with preoperative hypofractionated radiation in 15 patients with…NCT04193904·Houston, Texas

RecruitingA Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer.The purpose of this study is to assess the safety, tolerability and efficacy of XER-001 and identify a best dose for future studies.NCT07157033·Duarte, California and 4 others

TerminatedStudy to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.This study was conducted to advance new treatment for patients with metastatic or locally advanced cancers expressing Neurotensin receptor 1 (NTSR1).NCT03525392·Houston, Texas and 7 others

PreviousPage 15 of 22Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia